Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)

NACompletedINTERVENTIONAL
Enrollment

531

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

June 30, 2018

Conditions
HIV
Interventions
OTHER

Rapid ART initiation

Subjects offered the intervention who are eligible for antiretroviral therapy under South African guidelines will be offered the opportunity to initiate ART immediately, if possible on the same day as testing positive for HIV. Rapid testing technologies and an accelerated schedule will be used to allow all steps required prior to initiating ART to take place in approximately a half-day period.

Trial Locations (2)

2092

Thuthukani Primary Health Clinic, Johannesburg

Unknown

Themba Lethu Clinic, Helen Joseph Hospital, Johannesburg

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

University of Witwatersrand, South Africa

OTHER

lead

Boston University

OTHER

NCT01710397 - Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study) | Biotech Hunter | Biotech Hunter